legal representative of the group: Mr. Mu Huaguo is the vice president of Bengbu General Chamber of Commerce, Bengbu Guangcai Industry Promotion Association, individual and private association, chairman of Bengbu Private Entrepreneurs Association, member of the 1th and 11th CPPCC in Bengbu, and member of the 8th and 9th CPPCC in Anhui.
the backbone enterprises under the group include: Bengbu Fukang Battery Co., Ltd., Anhui Fukang Pharmaceutical Co., Ltd., Minsheng Guarantee Company, etc.
Bengbu Fukang Battery Co., Ltd. is located at No.44 Daqing Road, High-tech Zone, and was founded in 1992 with a registered capital of 1 million yuan. Specializing in the production and sales of all kinds of civil batteries, the factory covers an area of 45 mu, with more than 1 advanced battery production lines and more than 1 sets of special equipment for battery production. All the products are sold to more than 3 countries and regions in the international market. It is the largest battery production and export enterprise in Anhui Province, one of the top 1 private enterprises in Anhui Province, an export-oriented enterprise, and a AAA-level credit enterprise awarded by the Agricultural Bank of Anhui Province.
The registered trademarks of the company such as DOMEX, SUNBRIGHT, 333, GGG, Sun and Beast King are well received by the market, effectively establishing the corporate brand. The company has passed ISO92 quality certification, has the right to import and export, and has independent booths at the Canton Fair and China Fair. According to the spirit of the joint instruction of the State Economic and Trade Commission, the State Environmental Protection Bureau and other six ministries and commissions, in order to meet the market demand and the long-term development of enterprises, it is planned to invest 3 million yuan, requisition more than 4 mu of land, expand the existing factory area, and build 1 new production lines of R6P-type green batteries, with an annual output of 3 million units. On this basis, it is planned to develop the production of high-grade alkaline manganese batteries and continue to maintain the position of the vanguard in Anhui battery industry.
Anhui Fukang Pharmaceutical Co., Ltd. is a large-scale comprehensive pharmaceutical enterprise integrating R&D, production and sales of Chinese patent medicines in China, with a pharmaceutical history of more than 3 years. The company has first-class professionals, high-quality management team and modern production workshop, and can independently develop all kinds of national new drugs. After more than 3 years' development, the company now has a relatively high-level research and development system, manufacturing system and marketing system of Chinese patent medicine in China, and has formed a huge product group covering 7 dosage forms and 5 series, with 26 varieties of Chinese medicine, namely, the neurological series led by "Naoxing Syrup", the endocrine series led by "Liuwei Dihuang Oral Liquid", the gynecological series led by "Jujube Ginseng Mixture" and the Shenling series.
in 24, a new GMP-compliant factory building with an investment of more than 7 million yuan, covering an area of more than 6, square meters and an annual production capacity of 5 million yuan was completed and put into operation in Bengbu High-tech Industrial Development Zone, and passed the national GMP certification at one time on April 3, 24, thus taking the lead in entering the ranks of national GMP-compliant drug manufacturers! The second phase of the project will be officially launched in 26 and passed GMP certification in 27. By then, a modern Chinese medicine industrial park with an annual production capacity of 3-4 billion yuan will be formed.
With the development of social progress and technology, Fukang Pharmaceutical deeply feels that product renewal is the lifeblood of the enterprise. With the increasing expansion of Fukang Pharmaceutical and the increasing core competence of product research and development technology, and based on the industry background that biotechnology will become the leading industry in the 21st century, in order to achieve long-term development, Fukang Pharmaceutical finally decided on a diversified enterprise development strategy of "taking the modernization of traditional Chinese medicine as the main task and taking health care products and biological agents as the two wings". Fukang pharmaceutical fully cooperates with various professional colleges and research institutes at home and abroad in scientific research, and enriches Fukang's own technical strength with their professional strength to promote the research and development process of new products and industrialize scientific and technological achievements; For a long time, Fukang Pharmaceutical has always put science and technology first, adhering to the business philosophy of "rejuvenating the national traditional Chinese medicine industry with science and technology", always taking "scientific and technological innovation" as the strategic foundation of Fukang Pharmaceutical's foothold in society and long-term development, making full use of the advantages of combining modern science and technology with Millennium classic prescriptions, creating fine medicines with science and technology, and taking the road of modern Chinese medicine industry development, in order to provide more high-quality medical products for consumers. At the same time, the company will increase tea extract and ginkgo biloba in the future.